Collectively, the results of these studies show that HGF/c-Met axis is an effective multifaceted tumor regulator, which could have pivotal implications on the understanding of HCC mechanisms and the improvement of therapeutics. This evidence concerns the gene MET and hepatocellular carcinoma.